#her2-low

1 story

#advanced cancer #astrazeneca #breast cancer #cancer treatment #daiichi sankyo #drug approval #england #enhertu #nhs #nice #pharmaceutical pricing

Life-extending breast cancer drug now on NHS
After price negotiations, thousands of women with advanced HER2-low breast cancer will access Enhertu on the NHS from Thursday.
the Guardian · 1m